MYND Life Sciences

MYND Life Sciences is a medical biotechnology pharmaceutical research and development company focused on the development of neuropharmaceuticals and novel psilocybin-based drugs. The company advances the development of new psychedelic medicines through rigorous scientific research and clinical trials, while actively pursuing patents and safeguarding its intellectual property. Founded by Dr. Wilfred Jefferies and Dr. Lyle Oberg, MYND Life Sciences aims to improve mental health. Dr. Jefferies, a world-renowned neuroimmunologist, holds over 60 patents and has published 100 papers in prestigious medical journals, including *Nature* and *The Lancet*.